Is Krishna Institute of Medical Sciences the Best Stock in Its Sector? A Look at the Numbers
- September 16, 2026
- Posted by: Harsh Piplani
- Category: Market
Krishna Institute of Medical Sciences CMP Rs 766 (16 Sep 2026). Market cap Rs 32,204 Cr. ROE 10.74%. P/E 165.60x versus Industry P/E 67.99x.
Quick Answer
Krishna Institute of Medical Sciences is one of the names investors compare when screening the Healthcare sector, built on a 10.74% return on equity and a P/E of 165.60x against an Industry P/E of 67.99x. Krishna Institute of Medical Sciences Ltd operates a chain of multi-specialty hospitals across South India, offering tertiary and quaternary care services. Whether Krishna Institute of Medical Sciences is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.
Is Krishna Institute of Medical Sciences the best stock in its sector? The stock trades on the NSE at Rs 766 as of 16 September 2026, within its 52-week range of Rs 575.80 to Rs 858.00. Krishna Institute of Medical Sciences Ltd operates a chain of multi-specialty hospitals across South India, offering tertiary and quaternary care services.
Krishna Institute of Medical Sciences sits in the Healthcare sector, and its 10.74% ROE and 165.60x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P/E benchmark.
Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers
Click Here – Get Free Investment Predictions
About Krishna Institute of Medical Sciences
Krishna Institute of Medical Sciences Ltd operates a chain of multi-specialty hospitals across South India, offering tertiary and quaternary care services. At a market capitalisation of Rs 32,204 Cr, it is tracked as part of the Healthcare sector on Univest.
Is Krishna Institute of Medical Sciences the Best Stock in Its Sector?
Krishna Institute of Medical Sciences makes its case as the best stock in its sector primarily on valuation relative to its Industry P/E, combining a 10.74% ROE with a 165.60x P/E against the sector’s 67.99x Industry P/E. KIMS’ 165.60x P/E is far above the 67.99x Industry P/E and above Apollo Hospitals, Max Healthcare and Global Health in this comparison, one of the richest valuations in this batch relative to its 10.74% ROE.
| Metric | Krishna Institute of Medical Sciences |
|---|---|
| CMP (NSE) | Rs 766.45 |
| 52-Week High / Low | Rs 858.00 / Rs 575.80 |
| Market Cap | Rs 32,204 Cr |
| P/E (TTM) vs Industry P/E | 165.60x vs 67.99x |
| P/B | 8.59 |
| ROE | 10.74% |
| EPS (TTM) | Rs 4.63 |
| Dividend Yield | 0.00% |
| Debt to Equity | 1.89 |
Compare Krishna Institute of Medical Sciences Against Other Healthcare Sector Stocks
How Krishna Institute of Medical Sciences Compares Against Its Healthcare Sector Peers
The table below sets Krishna Institute of Medical Sciences against 3 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 3 peer companies.
| Company | Market Cap (Rs Cr) | P/E | ROE | Debt to Equity |
|---|---|---|---|---|
| Krishna Institute of Medical Sciences | 32,204 | 165.60 | 10.74% | 1.89 |
| Apollo Hospitals Enterprise | 1,25,093 | 57.59 | 20.48% | 0.90 |
| Max Healthcare Institute | 99,964 | 68.61 | 13.42% | 0.32 |
| Global Health | 38,921 | 70.47 | 14.05% | 0.30 |
| Peer average (3 companies) | – | 65.56 | 15.98% | 0.51 |
Against this peer set, Krishna Institute of Medical Sciences’s 10.74% ROE is below the 15.98% peer average, and its P/E of 165.60x runs above the peer average of 65.56x. KIMS’ 165.60x P/E is far above the 67.99x Industry P/E and above Apollo Hospitals, Max Healthcare and Global Health in this comparison, one of the richest valuations in this batch relative to its 10.74% ROE.
What Makes Krishna Institute of Medical Sciences Worth Watching in Healthcare
- Regional hospital scale: A multi-hospital network across South India gives KIMS scale advantages in procurement and specialist recruitment.
- Expansion-stage valuation: A 165.60x P/E against a 67.99x Industry P/E reflects the market pricing in significant future bed capacity and hospital additions.
- Moderate leverage for hospital capex: A debt to equity ratio of 1.89 is typical for a hospital operator funding new facility construction.
Krishna Institute of Medical Sciences Valuation: Is It Justified?
KIMS’ 165.60x P/E is far above the 67.99x Industry P/E and above Apollo Hospitals, Max Healthcare and Global Health in this comparison, one of the richest valuations in this batch relative to its 10.74% ROE. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.
Also read – Is Bata India the Best Stock in Its Sector? A Look at the Numbers
Download the Univest iOS App or Univest Android App to track Krishna Institute of Medical Sciences and other Healthcare sector stocks.
How to Track Krishna Institute of Medical Sciences Before You Invest
Before deciding whether Krishna Institute of Medical Sciences deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.
- Open the Univest Screener and search for Krishna Institute of Medical Sciences to view live price, valuation ratios, and peer comparisons within the Healthcare sector.
- Compare its P/E, P/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.
- Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
- Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.
Conclusion
Krishna Institute of Medical Sciences earns a place in the best stock in its sector conversation on the strength of a 10.74% ROE and a P/E of 165.60x against a 67.99x Industry P/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Is Krishna Institute of Medical Sciences the best stock in its sector?
Ans. Krishna Institute of Medical Sciences has a 10.74% ROE and trades at 165.60x P/E against a 67.99x Industry P/E, and compares below the peer average ROE of 15.98% in this article’s named comparison, so the answer depends on what an investor is prioritising.
What is the current share price of Krishna Institute of Medical Sciences?
Ans. Krishna Institute of Medical Sciences was trading at Rs 766.45 on the NSE as of 16 September 2026, within its 52-week range of Rs 575.80 to Rs 858.00.
What sector does Krishna Institute of Medical Sciences belong to?
Ans. Krishna Institute of Medical Sciences is classified under the Healthcare sector on Univest.
How does Krishna Institute of Medical Sciences compare to its sector peers on P/E?
Ans. Krishna Institute of Medical Sciences’s P/E of 165.60x is above the 65.56x average of the 3 named peers compared in this article.
What is Krishna Institute of Medical Sciences’s return on equity?
Ans. Krishna Institute of Medical Sciences reported a return on equity of 10.74%, which is below the 15.98% average of its named peers in this comparison.
Should I invest in Krishna Institute of Medical Sciences based on its sector position?
Ans. Krishna Institute of Medical Sciences’s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.
